US Business

SLB logged higher fourth-quarter revenue and said some of the challenges it faced last year are behind it, as it stands to benefit from increasing international activity.

CVC will pay $400 million in cash and up to $800 million in equity, and further payments could be due subject to Marathon’s financial performance between 2027 and 2029.

The animated sequel outgrossed “Avatar: Fire and Ash” to become Disney’s top film release of 2025.

David Sokol was seen as the next likely CEO of Berkshire Hathaway—until a controversy arose over his personal trades.

The drugmaker had recently been in discussions to acquire RevMed in a deal that could have valued the cancer-drug biotech at around $30 billion.

Clorox said the all-cash deal, which is being funded with debt, will help it expand further into the health and hygiene categories.

Once a leader of U.S. shale, Sheffield is tacking on a surprising new chapter to his career.

The London-listed company said the cash bid materially undervalues Beazley and its long-term prospects.

The testing industry has faced pressure since the pandemic, when many universities made exams optional.